Evidence for Disease Control with Erlotinib after Gefitinib Failure in Typical Gefitinib-Sensitive Asian Patients with Non-small Cell Lung Cancer

Details 詳細情報について

• CRID

  1363388844703840640

• DOI

  10.1097/jto.0b013e318168c801

• ISSN

  15560864

• Web Site

  https://api.elsevier.com/content/article/PII:S1556086415314386?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S1556086415314386?httpAccept=text/plain

• Data Source

  • Crossref